PMID: 9660028Jul 11, 1998Paper

Surgical adjuvant active specific immunotherapy for patients with stage III melanoma: the final analysis of data from a phase III, randomized, double-blind, multicenter vaccinia melanoma oncolysate trial

Journal of the American College of Surgeons
Marc K WallackL Rosen

Abstract

A phase III, randomized, double-blind, multicenter trial of active specific immunotherapy (ASI) using vaccinia melanoma oncolysate (VMO) was performed in patients with stage III (American Joint Commission on Cancer) melanoma to determine the efficacy of VMO to increase the disease-free interval (DFI) or overall survival (OS) in these patients. Two interim analyses of data from this trial were performed in May 1994 and June 1995. Although the results from these analyses showed no statistically significant improvement in DFI or OS in all patients using VMO, two subsets-men aged 44-57 years with one to five positive nodes and all patients with clinical stage I and pathologic stage II disease-showed an overall survival advantage with VMO therapy. A final analysis of data from this trial was performed in May 1996 and is reported here. The design of future melanoma vaccine trials is discussed based on information learned from this first randomized, multicenter trial of ASI therapy. A polyvalent VMO was prepared using melanoma cells derived from four melanoma cell lines and vaccinia vaccine virus (V). Patients were accrued from 11 United States institutions and were randomized by the Statistical Center at the University of Alabama, Bi...Continue Reading

References

Feb 1, 1979·Archives of Surgery·L H BarrL I Goldman
Oct 1, 1978·American Journal of Surgery·S Kaufman, J M Loré
Mar 15, 1992·Cancer·M F AvrilJ C Guillaume
Jun 1, 1989·The Journal of Experimental Medicine·B MukherjiM T Ergin
Jan 1, 1989·Seminars in Surgical Oncology·D L MortonR F Irie
Dec 1, 1988·The Journal of Surgical Research·Y BarnavonM K Wallack
Aug 15, 1995·Proceedings of the National Academy of Sciences of the United States of America·B MukherjiJ Meehan
Nov 1, 1994·Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy·N TanakaM K Wallack
Jul 5, 1994·Proceedings of the National Academy of Sciences of the United States of America·Y KawakamiS A Rosenberg
Apr 26, 1994·Proceedings of the National Academy of Sciences of the United States of America·Y KawakamiS A Rosenberg
Aug 12, 1993·Annals of the New York Academy of Sciences·P O Livingston
May 1, 1974·Canadian Family Physician Médecin De Famille Canadien·D S Birdsell

❮ Previous
Next ❯

Citations

Apr 28, 1999·Journal of Surgical Oncology·M R Hemmila, A E Chang
Jun 12, 2002·Current Treatment Options in Oncology·V K SondakL M Schuchter
Dec 21, 2000·Current Oncology Reports·L W ThompsonC L Slingluff
Dec 21, 2000·Current Oncology Reports·J Stebbing, M Gore
Jun 30, 2009·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Jacqueline Nuss ParkerJames M Markert
Nov 26, 2003·Surgery·Howard L Kaufman
May 15, 2003·The Surgical Clinics of North America·Charles Komen Brown, John M Kirkwood
Apr 27, 2000·Critical Reviews in Oncology/hematology·A J Bremers, G Parmiani
Feb 22, 2003·Journal of the American College of Surgeons·Kelli M BullardMichael P Spencer
Feb 19, 2000·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·J G Sinkovics, J C Horvath
Mar 26, 2011·Cancer Gene Therapy·R M Eager, J Nemunaitis
Feb 12, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Dmitriy ZamarinYuman Fong
Nov 3, 2005·Nature Clinical Practice. Oncology·Ahmad A TarhiniJohn M Kirkwood
Dec 5, 2002·Clinical and Experimental Dermatology·F O Nestle
Jan 22, 2003·Internal Medicine Journal·P Hersey
Aug 10, 2002·Seminars in Oncology·Alexander M M Eggermont, Martin Gore
Oct 31, 2002·Seminars in Oncology·Boris R Minev
May 1, 2006·Clinics in Colon and Rectal Surgery·Marc Singer, Matthew G Mutch
Mar 2, 2011·Cancer Biotherapy & Radiopharmaceuticals·Robert O Dillman
May 30, 2002·Annals of Surgery·Rebekah R WhiteHilliard F Seigler
Mar 7, 2002·Current Opinion in Oncology·Alexander M M Eggermont
Feb 3, 2007·Current Opinion in Oncology·Giorgio ParmianiLicia Rivoltini
Nov 24, 1999·Immunological Reviews·J Schlom, J W Hodge
Aug 24, 2010·Journal of Translational Medicine·Jochen T SchaeferCraig L Slingluff
Nov 15, 2001·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·E C Hsueh
Jul 17, 2003·American Journal of Clinical Dermatology·Alexander M M Eggermont, Cornelis J A Punt
Nov 4, 2000·Expert Opinion on Investigational Drugs·E R Smith, E A Chiocca
Jan 5, 2002·Expert Opinion on Investigational Drugs·Peter Hersey
Feb 3, 2009·The Surgical Clinics of North America·Katharine YaoDavid J Winchester
Apr 25, 2006·Surgical Oncology Clinics of North America·Mark B Faries
Oct 19, 2004·Clinical Oncology : a Journal of the Royal College of Radiologists·J SpicerH Pandha
Dec 20, 2008·Expert Review of Vaccines·Philippe Fournier, Volker Schirrmacher
Jun 23, 2011·Expert Review of Vaccines·Oliver KleinJonathan Cebon
Nov 14, 2001·Dermatologic Clinics·P BonaccorsiC A Armstrong
Nov 16, 2005·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Christiane VoitWolfram Sterry
Jan 28, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Zheng LvDe-Shan Li
Apr 29, 1999·Annals of Medicine·D Herlyn, B Birebent
Mar 5, 2013·Expert Opinion on Biological Therapy·Robert O DillmanGabriel Nistor

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.